Abstract PD4-04: Updated results of tucatinib vs placebo added to trastuzumab and capecitabine for patients with previously treated HER2-positive metastatic breast cancer with brain metastases (HER2CLIMB)Nancy U. Lin, Eric P. Winer, Vandana G. Abramson et al.|Cancer Research|2022Cited by 7